Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Piloting FUERTE: Federally qUalified Health Centers Engaging Hispanic Men at Risk of diabeTEs (FUERTE)

17. november 2026 opdateret af: Weill Medical College of Cornell University

Aim 3 Piloting FUERTE: Federally qUalified Health Centers Engaging Hispanic Men at Risk of diabeTEs

The goal of this study is to learn whether FUERTE (Federally qUalified Health Centers Engaging Hispanic Men at Risk of diabeTEs) can facilitate referrals of Hispanic men with prediabetes to the Diabetes Prevention Program (DPP) and support their continued engagement in the program.

The main questions it aims to answer are:

Does implementation of the FUERTE strategy increase the number of DPP-eligible Hispanic men who are referred to and enrolled in the DPP? Does implementation of the FUERTE strategy improve engagement in the DPP and result in greater improvements in weight and hemoglobin A1C among Hispanic men participating in the program?

FUERTE consists of three components:

  1. Information sessions for healthcare providers to increase awareness of the DPP.
  2. Text messages sent to DPP-eligible Hispanic men reminding them of appointments and encouraging discussions about prediabetes with healthcare providers.
  3. Interactive WhatsApp group messages for Hispanic men referred to the DPP, providing tailored content and discussion prompts related to each core DPP session.

Participants will:

  • Complete a survey before enrolling in the DPP.
  • Complete a survey after completing the DPP.
  • Those participating post-implementation of FUERTE will (1) receive text-messages, reminding them of their appointments and encouraging discussions about prediabetes with providers, and (2) receive interactive group-messages, delivered through WhatsApp, to supplement the standard of care DPP with tailored topics and prompts.

Studieoversigt

Status

Ikke rekrutterer endnu

Betingelser

Intervention / Behandling

Detaljeret beskrivelse

The goal of this single-site pilot implementation trial is to learn if FUERTE (Federally qUalified Health Centers Engaging Hispanic Men at Risk of diabeTEs), a multi-component implementation strategy for Federally Qualified Health Centers, can feasibly facilitate referrals of Hispanic men with prediabetes to the Diabetes Prevention Program (DPP) and support their continued engagement in the program. FUERTE consists of 3 components: Component 1, information sessions to providers, to increase awareness of the DPP; Component 2, text-messages, delivered through existing appointment notification systems, sent to DPP-eligible Hispanic men, to remind them of their appointments and encourage discussions about prediabetes with providers; and Component 3, interactive group-messages, delivered through WhatsApp, to Hispanic men referred to the DPP, to supplement standard of care (i.e. standard DPP) with tailored topics and prompts relating to each core session of the DPP.

The main questions it aims to answer is whether:

Primary Hypothesis: FUERTE increases the proportion of DPP-eligible Hispanic men seen by a provider who are (1) referred to a Nutritionist for management of prediabetes, and (2) enrolled in a DPP.

Secondary Hypothesis: FUERTE increases (1) the proportion of providers referring DPP-eligible men for prediabetes management, and (2) the mean number of weeks Hispanic men attend the core component of the DPP.

Researchers will compare the results of participants seen by providers post-implementation of FUERTE with those seen pre-implementation of FUERTE.

Participants will:

Complete a survey before enrolling in the DPP, and after completing the program.

Those participating post-implementation of FUERTE will (1) receive text-messages, delivered through existing appointment notification systems, reminding them of their appointments and encouraging discussions about prediabetes with providers, and (2) receive interactive group-messages, delivered through WhatsApp, to supplement standard of care (i.e. standard DPP) with tailored topics and prompts relating to each core session of the DPP.

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

50

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Studiesteder

    • New York
      • New York, New York, Forenede Stater, 10065
        • Weill Cornell Medicine
        • Kontakt:
        • Ledende efterforsker:
          • Christopher J Gonzalez, MD MS

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år til 99 år (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Han

Beskrivelse

Inclusion Criteria:

  • Self-reported Hispanic ethnicity and men
  • At least 18 years old
  • Have a body mass index (BMI) =>25 kg/m2
  • Have a documented HbA1c of 5.7%-6.4% within one year

Exclusion Criteria:

  • Life expectancy <12 months
  • not planning to stay in the geographic area for at least 6 months
  • diabetes based on an ICD-10 code in the previous 3 years
  • does not speak English or Spanish
  • present with a condition or abnormality (e.g., significant neurocognitive dysfunction) that in the opinion of the Investigator would compromise the ability of the patient to provide informed consent for the study activities, or the quality of the data

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Sundhedstjenesteforskning
  • Tildeling: Ikke-randomiseret
  • Interventionel model: Sekventiel tildeling
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: FUERTE Arm

Outside of this study, as part of their standard care, all participants will receive the Diabetes Prevention Program (DPP) and visits with the nutritionist at their site.

Participants in this arm of the study will complete a survey before enrolling in the DPP, and after completing the program. Participants will receive interactive group-messages, delivered through WhatsApp, to supplement standard of care (i.e. standard DPP) with tailored topics and prompts relating to each core session of the DPP.

Participants will complete a survey before enrolling in the Diabetes Prevention Program (DPP), and after completing the program. Participants will receive interactive group-messages, delivered through WhatsApp, to supplement standard of care (i.e. standard DPP) with tailored topics and prompts relating to each core session of the DPP.

Participants will complete a survey before enrolling in the Diabetes Prevention Program (DPP), and after completing the program.

Aktiv komparator: Standard Care

Outside of this study, as part of their standard care, all participants will receive the Diabetes Prevention Program (DPP) and visits with the nutritionist at their site.

Participants in this arm of the study will complete a survey before enrolling in the DPP, and after completing the program.

Participants will complete a survey before enrolling in the Diabetes Prevention Program (DPP), and after completing the program.

Andet: Referring Providers

Referring Providers are assessed Pre and Post Implementation for the proportion of Providers seeing Diabetes Prevention Program (DPP) eligible men who then referred eligible men for Prediabetes Management.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Tidsramme
The proportion of Diabetes Prevention Program-eligible Hispanic men seen by a provider and referred to a Nutritionist for management of prediabetes
Tidsramme: 1 year
1 year
DPP Enrollment: The proportion of eligible Hispanic men enrolled in the Diabetes Prevention Program
Tidsramme: 1 year
1 year

Sekundære resultatmål

Resultatmål
Tidsramme
Mean number of weeks attending the Core Component of the Diabetes Prevention Program, out of 16 possible
Tidsramme: 6 months
6 months
Mean change in weight (kg) from baseline at 6 months
Tidsramme: Baseline, 6 months
Baseline, 6 months
Mean change in A1C (%) from baseline at 6 months
Tidsramme: Baseline, 6 months
Baseline, 6 months
Referring Providers: The proportion of Providers referring eligible Hispanic men to the Diabetes Prevention Program
Tidsramme: 1 year
1 year
Referring Providers: The number of referrals placed by a Provider
Tidsramme: 1 year
1 year

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Samarbejdspartnere

Efterforskere

  • Ledende efterforsker: Christopher J Gonzalez, MD MS, Weill Medical College of Cornell University

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Generelle publikationer

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Anslået)

1. december 2026

Primær færdiggørelse (Anslået)

1. december 2028

Studieafslutning (Anslået)

1. december 2029

Datoer for studieregistrering

Først indsendt

6. oktober 2026

Først indsendt, der opfyldte QC-kriterier

12. oktober 2026

Først opslået (Faktiske)

16. oktober 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

18. november 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

17. november 2026

Sidst verificeret

1. november 2026

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • 26-06030420
  • K23DK139410-01A1 (U.S. NIH-bevilling/kontrakt)

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

JA

IPD-planbeskrivelse

All of the individual participant data collected during the trial, after deidentification.

IPD-delingstidsramme

Immediately following publication. No end date.

IPD-delingsadgangskriterier

Anyone who wishes to access the data.

IPD-deling Understøttende informationstype

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE
  • CSR

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .